Pakistan Pharmaceutical Manufacturers Association

Pakistan Pharmaceutical Manufacturers Association Pakistan has a vibrant and forward-looking Pharma Industry.

With over 500 manufacturing units we are working to provide accessibility to affordable lifesaving medicines

๐Ÿ›๏ธ ๐’๐ž๐ง๐š๐ญ๐ž ๐’๐ญ๐š๐ง๐๐ข๐ง๐  ๐‚๐จ๐ฆ๐ฆ๐ข๐ญ๐ญ๐ž๐ž ๐จ๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐Œ๐ž๐ž๐ญ๐ข๐ง๐  โ€” ๐Š๐š๐ซ๐š๐œ๐ก๐ขPPMA presented the pharmaceutical industry's perspective on key ...
10/08/2026

๐Ÿ›๏ธ ๐’๐ž๐ง๐š๐ญ๐ž ๐’๐ญ๐š๐ง๐๐ข๐ง๐  ๐‚๐จ๐ฆ๐ฆ๐ข๐ญ๐ญ๐ž๐ž ๐จ๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐Œ๐ž๐ž๐ญ๐ข๐ง๐  โ€” ๐Š๐š๐ซ๐š๐œ๐ก๐ข

PPMA presented the pharmaceutical industry's perspective on key sector issues, including the deregulation of non-essential medicines. The meeting was presided over by Senator Aamir Chishti, Chairman of the Standing Committee.

๐’๐œ๐š๐ฅ๐ข๐ง๐  ๐‹๐จ๐œ๐š๐ฅ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐„๐ฑ๐ฉ๐จ๐ซ๐ญ ๐„๐ฑ๐ฉ๐š๐ง๐ฌ๐ข๐จ๐ง!Building on recent International B2B Agreements, the Pakistan Pha...
31/07/2026

๐’๐œ๐š๐ฅ๐ข๐ง๐  ๐‹๐จ๐œ๐š๐ฅ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐„๐ฑ๐ฉ๐จ๐ซ๐ญ ๐„๐ฑ๐ฉ๐š๐ง๐ฌ๐ข๐จ๐ง!

Building on recent International B2B Agreements, the Pakistan Pharmaceutical Manufacturers Association (PPMA) and health authorities are working together to scale local manufacturing of APIs, Vaccines, and Biotech.

Through accelerated technology transfer, this drive is set to transform Pakistan into a powerful regional pharma export hub! โœˆ๏ธ๐Ÿšข

DRAP has officially issued draft amendments regarding the Drugs Labelling and Packing Rules and is requesting feedback f...
30/07/2026

DRAP has officially issued draft amendments regarding the Drugs Labelling and Packing Rules and is requesting feedback from stakeholders.

We urge all pharmaceutical manufacturers to review the draft to support:
โœ… Supply-chain software integration
โœ… Regulatory compliance
โœ… Patient safety
Stay proactive and share your valuable inputs today.

๐Ÿค Major Milestone for Pakistanโ€™s Pharmaceutical Sector!The Pak-China Business Conference concluded with $1.4 Billion in ...
29/07/2026

๐Ÿค Major Milestone for Pakistanโ€™s Pharmaceutical Sector!

The Pak-China Business Conference concluded with $1.4 Billion in total investment commitments, including 42 final-day deals! ๐Ÿš€

This historic partnership focuses on:

Local Active Pharmaceutical Ingredient (API) Manufacturing
Vaccine Production
Advanced Medical Equipment

These commitments mark a pivotal step toward reducing reliance on imports, boosting exports, and strengthening national healthcare self-reliance.

5th Central Executive Committee MeetingThe Pakistan Pharmaceutical Manufacturers Association (PPMA) successfully convene...
28/07/2026

5th Central Executive Committee Meeting

The Pakistan Pharmaceutical Manufacturers Association (PPMA) successfully convened its 5th CEC Meeting, chaired by Dr. Mohammad Tahir Azam. Industry leaders gathered to align on key strategic priorities, address sector challenges, and foster collaborative decision-making to drive Pakistan's pharma growth forward.

Stronger together for a healthier tomorrow.Tomorrow in Islamabad, the Pakistanโ€“China B2B Investment Conference kicks off...
16/07/2026

Stronger together for a healthier tomorrow.

Tomorrow in Islamabad, the Pakistanโ€“China B2B Investment Conference kicks off, bringing together over 450+ firms to forge the Sino-Pak Pharma Alliance.

With the support of DRAP, BOI, and SIFC, this summit isn't just about discussionsit is about immediate, project-driven results. Dedicated on-site regulatory desks will be active to instantly fast-track licensing and joint venture approvals, paving the way for seamless international collaboration.

Stay tuned as we embark on this exciting new chapter for Pakistan's pharmaceutical industry.

๐ƒ๐‘๐€๐ ๐Œ๐š๐ง๐๐š๐ญ๐ž๐ฌ ๐Ÿ๐ƒ ๐๐š๐ซ๐œ๐จ๐๐ž๐ฌ & ๐’๐ฒ๐ซ๐ข๐ง๐ ๐ž ๐”๐ฉ๐ ๐ซ๐š๐๐ž๐ฌA new era of healthcare transparency begins. The Drug Regulatory Authority o...
07/07/2026

๐ƒ๐‘๐€๐ ๐Œ๐š๐ง๐๐š๐ญ๐ž๐ฌ ๐Ÿ๐ƒ ๐๐š๐ซ๐œ๐จ๐๐ž๐ฌ & ๐’๐ฒ๐ซ๐ข๐ง๐ ๐ž ๐”๐ฉ๐ ๐ซ๐š๐๐ž๐ฌ

A new era of healthcare transparency begins. The Drug Regulatory Authority of Pakistan (DRAP) has established critical regulatory timelines to safeguard public health:

The Pakistan Pharmaceutical Manufacturers Association (PPMA) strongly welcomes these landmark regulatory milestones, standing united with DRAP in this definitive victory for national patient safety and pharmaceutical innovation. ๐Ÿ‡ต๐Ÿ‡ฐโœจ

๐๐ฎ๐๐ ๐ž๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”-๐Ÿ๐Ÿ•: ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ฌ ๐ƒ๐ฎ๐ญ๐ฒ ๐‘๐ž๐ฆ๐จ๐ฏ๐ž๐ ๐จ๐ง ๐‚๐š๐ง๐œ๐ž๐ซ ๐€๐๐ˆ๐ฌUnder the newly announced Federal Budget 2026-27, the government has ...
06/07/2026

๐๐ฎ๐๐ ๐ž๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”-๐Ÿ๐Ÿ•: ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ฌ ๐ƒ๐ฎ๐ญ๐ฒ ๐‘๐ž๐ฆ๐จ๐ฏ๐ž๐ ๐จ๐ง ๐‚๐š๐ง๐œ๐ž๐ซ ๐€๐๐ˆ๐ฌ

Under the newly announced Federal Budget 2026-27, the government has officially exempted customs duties on critical cancer-related Active Pharmaceutical Ingredients (APIs). This public health relief will significantly reduce manufacturing costs and make life-saving cancer treatments much more affordable across Pakistan.

02/07/2026

A Historic Milestone for Pakistanโ€™s Pharmaceutical Sector! ๐ŸŒ

The Pakistan Pharmaceutical Manufacturers Association (PPMA) extends its warmest congratulations to Dr. Obaidullah (CEO DRAP) and the entire Drug Regulatory Authority of Pakistan (DRAP) team on achieving a major global recognition!

Pakistanโ€™s formal admission to the International Pharmaceutical Regulators Programme (IPRP) as a Member Regulatory Authority is a moment of immense pride. This monumental achievement stands as a testament to DRAP's unwavering commitment to regulatory excellence, paving the way for global trust and expanded horizons for Pakistani pharmaceuticals on the world stage. โœจ

Global Standards Imminent ๐ŸŒ๐Ÿš€Pakistan is officially on the fast track to achieving WHO Level 3 Regulatory Certification! ...
29/06/2026

Global Standards Imminent ๐ŸŒ๐Ÿš€

Pakistan is officially on the fast track to achieving WHO Level 3 Regulatory Certification! With DRAP accelerating compliance audits, this massive milestone will validate our regulatory system and unlock export doors to over 150 countries worldwide.

PPMA stands committed to driving national manufacturing toward global horizons!

Address

House # 474, Street 34, I-8
Islamabad
44790

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00
Saturday 09:00 - 17:00

Telephone

+92514435105

Website

Alerts

Be the first to know and let us send you an email when Pakistan Pharmaceutical Manufacturers Association posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pakistan Pharmaceutical Manufacturers Association:

Shortcuts

Share

Category